Objective: This study was designed to investigate whether Complex Regional
Pain Syndrome type I (CRPS I) could be linked to any previous infection.
Patients: Fifty-two patients with CRPS I of one extremity were screened for
the presence of antibodies against mostly neurotropic microorganisms.
Results: Of these 52 patients, none had antibodies against Treponema pallid
um. Borrelia burgdorferi. or HTLV-I. Only four patients were positive for C
ampylobacter jejuni. For cytomegalovirus, Epstein-Barr virus, herpes simple
x virus, and Toxoplasma gondii, seroprevalences were similar to control val
ues. The total seroprevalence of Parvovirus B19 in our CRPS population was
77%, which was significantly higher than in an independent Dutch population
group (59%). Seroprevalence in lower extremity CRPS I (94%) was significan
tly higher than in upper extremity CRPS I patients (68%). In this study all
patients were seropositive for varicella tester virus (VZV) antibodies, bu
t a high prevalence of VZV antibodies is similar to its prevalence in a nor
mal population (>90%).
Conclusions: In this study we found a significantly higher seroprevalence o
f parvovirus B19 in CRPS I and this if most striking in lower extremity CRP
S I patients. Further serologic research in other geographic areas is neede
d to provide additional information about a potential role of Parvovirus B1
9 or other microorganisms in the etiopathogenesis of CRPS I.